NewsConcerns explains that Molnupiravir, Merck’s new anti-viral, has issues with both efficacy and safety.
Debunking the BBC debunk of ivermectin. U.K. Nurse/Teacher John Campbell Breaks Down the BBC’s “Reality Check” on Ivermectin by Using Science to Compare IVM to Molnupiravir.
Transcript of Dr. Kory's video message on the U.S. Deal to Give $1.2 Billion Taxpayer Dollars to Merck Instead of distributing safe, effective, inexpensive ivermectin